Actinium Pharmaceuticals, Inc. (ATNM) vs Gain Therapeutics, Inc. (GANX)

• Actinium Pharmaceuticals, Inc. ATNM 1.42 ▲ +9.23%
• Gain Therapeutics, Inc. GANX 1.00 ▲ +4.17%

Actinium Pharmaceuticals, Inc. and Gain Therapeutics, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Gain Therapeutics, Inc. are of similar size ($41.9M and $40.9M). Gain Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against 18.4%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Actinium Pharmaceuticals, Inc. leads on 11 and Gain Therapeutics, Inc. on 5.